The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
New Board of Directors and management team at Suven Pharma also appointed
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
30 beneficiaries avail of services per minute
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Subscribe To Our Newsletter & Stay Updated
